By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy
Global Diphtheria, Pertussis, and Tetanus Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Diphtheria, Pertussis, and Tetanus Vaccine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Diphtheria, Pertussis, and Tetanus Vaccine market. Further, it explains the major drivers and regional dynamics of the global Diphtheria, Pertussis, and Tetanus Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
- Johnson & Johnson
- GlaxoSmithKline
- Sanofi
- Lanzhou Institute of Biological
- Merck
- Novartis
- AstraZeneca
- Emergent
- Astellas
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Diphtheria, Pertussis, and Tetanus Vaccine Segment by Type
- DTaP
- Td
- Tdap
Diphtheria, Pertussis, and Tetanus Vaccine Segment by Application
- Hospitals
- Clinics
- Vaccination Centers
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Diphtheria, Pertussis, and Tetanus Vaccine production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Diphtheria, Pertussis, and Tetanus Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Diphtheria, Pertussis, and Tetanus Vaccine, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Diphtheria, Pertussis, and Tetanus Vaccine, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Diphtheria, Pertussis, and Tetanus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Diphtheria, Pertussis, and Tetanus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Diphtheria, Pertussis, and Tetanus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Diphtheria, Pertussis, and Tetanus Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Johnson & Johnson, GlaxoSmithKline, Sanofi, Lanzhou Institute of Biological, Merck, Novartis, AstraZeneca, Emergent and Astellas, etc.
Table of Contents
1 Report Overview
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Research Scope
1.2 Market Segment by Type
1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market Segment by Application
1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Market Production
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (2017-2028)
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region
2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Production by Region (2017-2022)
2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Production by Region (2023-2028)
2.3.3 North America
2.3.4 Europe
2.3.5 Japan
2.3.6 China
2.3.7 South Korea
2.3.8 India
2.4 Market Dynamics
2.4.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Trends
2.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
2.4.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
2.4.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Estimates and Forecasts 2017-2028
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Estimates and Forecasts 2017-2028
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Sales
3.4.1 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Sales (2017-2022)
3.4.2 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Sales (2023-2028)
3.5 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Revenue
3.5.1 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Revenue (2017-2022)
3.5.2 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Regions by Revenue (2023-2028)
3.5.3 North America
3.5.4 Europe
3.5.5 Asia-Pacific
3.5.6 Latin America
3.5.7 Middle East & Africa
4 Competition by Manufacturers
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers
4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers
4.2.1 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers by Sales (2017-2022)
4.2.2 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Share by Sales (2017-2022)
4.2.3 Global Top 10 and Top 5 Companies by Diphtheria, Pertussis, and Tetanus Vaccine Sales in 2021
4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers
4.3.1 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers by Revenue (2017-2022)
4.3.2 Global Top Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Share by Revenue (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
4.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
5.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Type (2017-2022)
5.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Type (2023-2028)
5.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type
5.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Type (2017-2022)
5.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type
5.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022)
5.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
6.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Application (2017-2022)
6.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Application (2023-2028)
6.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application
6.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Application (2017-2022)
6.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application
6.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022)
6.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Company
7.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022)
7.1.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022)
7.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
7.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
7.2.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
7.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
7.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
7.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
7.4 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
7.4.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
7.4.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
7.4.3 U.S.
7.4.4 Canada
8 Europe
8.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Company
8.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022)
8.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022)
8.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
8.2.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
8.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
8.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
8.3.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
8.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
8.4.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
8.4.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Russia
9 Asia Pacific
9.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Company
9.1.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022)
9.1.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022)
9.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
9.2.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
9.2.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
9.3 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
9.3.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
9.3.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
9.4 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Region
9.4.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2028)
9.4.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2028)
9.4.3 China
9.4.4 Japan
9.4.5 South Korea
9.4.6 India
9.4.7 Australia
9.4.8 Taiwan
9.4.9 Indonesia
9.4.10 Thailand
9.4.11 Malaysia
9.4.12 Philippines
10 Latin America
10.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Company
10.1.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022)
10.1.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022)
10.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
10.2.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
10.2.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
10.3 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
10.3.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
10.3.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
10.4 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
10.4.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
10.4.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
10.4.3 Mexico
10.4.4 Brazil
10.4.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Breakdown by Company
11.1.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022)
11.1.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022)
11.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
11.2.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
11.2.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
11.3 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
11.3.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
11.3.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
11.4 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Country
11.4.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
11.4.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
11.4.3 Turkey
11.4.4 Saudi Arabia
11.4.5 U.A.E
12 Company Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Overview
12.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.1.5 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.1.6 Johnson & Johnson Recent Developments
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Overview
12.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.2.5 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.2.6 GlaxoSmithKline Recent Developments
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Overview
12.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.3.5 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.3.6 Sanofi Recent Developments
12.4 Lanzhou Institute of Biological
12.4.1 Lanzhou Institute of Biological Corporation Information
12.4.2 Lanzhou Institute of Biological Overview
12.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.4.5 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.4.6 Lanzhou Institute of Biological Recent Developments
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Overview
12.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.5.5 Merck Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.5.6 Merck Recent Developments
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Overview
12.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.6.5 Novartis Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.6.6 Novartis Recent Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Corporation Information
12.7.2 AstraZeneca Overview
12.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.7.5 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.7.6 AstraZeneca Recent Developments
12.8 Emergent
12.8.1 Emergent Corporation Information
12.8.2 Emergent Overview
12.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.8.5 Emergent Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.8.6 Emergent Recent Developments
12.9 Astellas
12.9.1 Astellas Corporation Information
12.9.2 Astellas Overview
12.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
12.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Products and Services
12.9.5 Astellas Diphtheria, Pertussis, and Tetanus Vaccine SWOT Analysis
12.9.6 Astellas Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Diphtheria, Pertussis, and Tetanus Vaccine Value Chain Analysis
13.2 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Diphtheria, Pertussis, and Tetanus Vaccine Production Mode & Process
13.4 Diphtheria, Pertussis, and Tetanus Vaccine Sales and Marketing
13.4.1 Diphtheria, Pertussis, and Tetanus Vaccine Sales Channels
13.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
13.5 Diphtheria, Pertussis, and Tetanus Vaccine Customers
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of DTaP
Table 3. Major Manufacturers of Td
Table 4. Major Manufacturers of Tdap
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region (2017-2022) & (K Units)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2017-2022)
Table 9. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region (2023-2028) & (K Units)
Table 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2023-2028)
Table 11. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends
Table 12. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
Table 13. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 14. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
Table 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K Units)
Table 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2022)
Table 18. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K Units)
Table 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2023-2028)
Table 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2022)
Table 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2023-2028)
Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity Market Share by Manufacturers (2017-2022)
Table 26. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Manufacturers (2017-2022) & (K Units)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Manufacturers (2017-2022)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 29. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Manufacturers (2017-2022)
Table 30. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 31. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 32. Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturers 2017-2022 (USD/Unit)
Table 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Diphtheria, Pertussis, and Tetanus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2021)
Table 35. Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base Distribution and Headquarters
Table 36. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 37. Date of Key Manufacturers Enter into Diphtheria, Pertussis, and Tetanus Vaccine Market
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 40. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 41. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Type (2017-2022)
Table 42. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Type (2023-2028)
Table 43. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 44. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 45. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2017-2022)
Table 46. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2023-2028)
Table 47. Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 49. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Application (2017-2022)
Table 52. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Application (2023-2028)
Table 53. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 54. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 55. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Application (2017-2022)
Table 56. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Application (2023-2028)
Table 57. Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 58. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 59. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022) & (K Units)
Table 60. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2017-2022)
Table 61. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 62. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2017-2022)
Table 63. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 64. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 65. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 66. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 67. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 68. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 69. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 70. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 71. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K Units)
Table 72. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K Units)
Table 73. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 74. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 75. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022) & (K Units)
Table 76. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2017-2022)
Table 77. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 78. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2017-2022)
Table 79. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 80. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 81. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 82. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 83. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 84. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 85. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 86. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 87. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K Units)
Table 88. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K Units)
Table 89. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 90. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 91. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022) & (K Units)
Table 92. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2017-2022)
Table 93. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 94. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2017-2022)
Table 95. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 96. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 97. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 99. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 100. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 101. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 102. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 103. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K Units)
Table 104. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K Units)
Table 105. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 106. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 107. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022) & (K Units)
Table 108. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2017-2022)
Table 109. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 110. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2017-2022)
Table 111. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 112. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 113. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 114. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 115. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 116. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 117. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 118. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 119. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K Units)
Table 120. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K Units)
Table 121. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 122. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Company (2017-2022) & (K Units)
Table 124. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Company (2017-2022)
Table 125. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Company (2017-2022)
Table 127. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K Units)
Table 128. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K Units)
Table 129. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 131. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K Units)
Table 132. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K Units)
Table 133. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 134. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Mil
Write comment about above report:
Related Reports
|
Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Research Report 2023
DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescen... |
|
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2023
Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, ... |
|
Global Diphtheria Tetanus Pertussis Mix Vaccine for Children Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Diphtheria Tetanus Pertussis Mix Vaccine for Children market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % du... |
|
Global Diphtheria Tetanus Pertussis Vaccine Market Research Report 2023
The DPT vaccine or DTP vaccine is a class of combination vaccines against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.The vaccine components include diphtheria and tetanus toxoids and either killed whole c... |
|
Global Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine Market Research Report 2021, Forecast to 2026
Diphtheria, tetanus, and acellular pertussis vaccine (also known as DTaP) is a combination immunizing agent given by injection to protect against infections caused by diphtheria, tetanus (lockjaw), and pertussis (whooping cough). We aims to pr... |
|
Global Diphtheria,Tetanus and Acellular Pertussis Combined Vaccine Professional Survey Report 2021, Forecast to 2026
Diphtheria, tetanus, and acellular pertussis vaccine (also known as DTaP) is a combination immunizing agent given by injection to protect against infections caused by diphtheria, tetanus (lockjaw), and pertussis (whooping cough). We aims to pr... |
|
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Research Report 2022 Professional Edition
The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at 2491.79 Million USD in 2021 and will grow with a CAGR of 4.02% from 2021 to 2027, based on HNY Research newly published report. The prime objective of this report is to ... |
|
Global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine Market Insights and Forecast to 2028
Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diphtheria, Tetanus, and Pertussis (DTaP) Vaccine market will be able to gain the upper hand... |
|
Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Insights and Forecast to 2028
Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market will be able ... |
|
Global Diphtheria, Pertussis, and Tetanus (DTP) Vaccine Market Research Report 2021 - Impact of COVID-19 on the Market
The Diphtheria, Pertussis, and Tetanus (DTP) Vaccine market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026. Considering the influenc... |
|
Global Diphtheria, Pertussis, and Tetanus Vaccine Market Insights, Forecast to 2028
Diphtheria, Pertussis, and Tetanus Vaccine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Diphtheria, Pertussis, and Tetanus Vaccine market will be able to gain the upper hand as they use t... |
We are on:
Why ReportsnReports.com?
- 500,000 market research reports and growing.
- Top Fortune 500 Organizations trust us for research data.
- 24/7 support on call as well as emails.
- Your Details are safe with us.
- Free support for your research requirements.
- Report Delivery: Email
- Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays